Publications by authors named "Frank Vladich"

The PIK3CA gene at chromosome 3q26.32 was found to be amplified in up to 45% of patients with squamous cell carcinoma of the lung. The strong correlation between PIK3CA amplification and increased phosphatidylinositol 3-kinase (PI3K) pathway activities suggested that PIK3CA gene copy number is a potential predictive biomarker for PI3K inhibitors.

View Article and Find Full Text PDF

The purpose of this study was to develop and analytically and functionally validate a new human papillomavirus (HPV) in-situ hybridization (ISH) assay and to determine whether the use of this assay combined with hemotoxylin and eosin (H&E) staining could potentially improve the diagnostic accuracy of interpreting cervical intraepithelial neoplasia (CIN) in human cervical tissue specimens. An automated HPV ISH assay was developed using probes that targeted the broad spectrum of HPV genotypes most commonly associated with CIN. In an exploratory study, tissue sections (n=118) were stained with H&E alone and H&E with HPV ISH and evaluated by 6 general surgical pathologists.

View Article and Find Full Text PDF

Microsporidia are obligate intracellular parasites. Microsporidian spores infect a wide variety of hosts, including humans. The spores may be found in infected hosts' urine and feces, thus waterborne transmission is possible.

View Article and Find Full Text PDF

Genetic factors are known to strongly influence susceptibility to allergic inflammation. The Th2 cytokine IL-13 is a central mediator of allergy and asthma, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13+2044GA is expected to result in the nonconservative replacement of arginine 130 (R130) with glutamine (Q).

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Frank Vladich"

  • Frank Vladich's research primarily focuses on the development and validation of diagnostic assays, particularly in relation to cancers and viral infections, highlighting the importance of biomarkers in patient treatment and diagnosis.
  • His studies on the PIK3CA gene indicate its potential role as a predictive biomarker for PI3K inhibitors in lung squamous cell carcinoma, emphasizing the need for targeted therapies.
  • Additionally, Vladich has explored the application of HPV in-situ hybridization (ISH) to enhance the diagnostic accuracy of cervical intraepithelial neoplasia, showcasing the integration of molecular techniques in pathology. *